Telmisartan
Telmisartan is a premier, highly lipophilic angiotensin II receptor blocker (ARB) that features an exceptionally long half-life for sustained cardiovascular control. It selectively targets and inhibits the AT1 receptor subtype, fully preventing angiotensin II from constricting the blood vessels. This sustained action reduces total peripheral resistance, supports natural endothelial flexibility
Hypertension Management
Cardiovascular Risk Reduction
Blood Pressure Control
Hypertension Management
Cardiovascular Risk Reduction
Blood Pressure Control
High Purity & Efficacy
USP / BP / EP / IP Grade Compliance
Stringent Quality Control & Batch Consistency
Pharmaceutical Formulations
Oral Solid Dosage (Tablets & Capsules)
Sterile Formulations / Injectables (where applicable)
Custom API Compounding